NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections
SourceThe Journal of Infectious Diseases, 207, 4, (2013), pp. 656-60
Article / Letter to editor
Display more detailsDisplay less details
The Journal of Infectious Diseases
SubjectN4i 3: Poverty-related infectious diseases NCMLS 1: Infection and autoimmunity
We established a new field clone of Plasmodium falciparum for use in controlled human malaria infections and vaccine studies to complement the current small portfolio of P. falciparum strains, primarily based on NF54. The Cambodian clone NF135.C10 consistently produced gametocytes and generated substantial numbers of sporozoites in Anopheles mosquitoes and diverged from NF54 parasites by genetic markers. In a controlled human malaria infection trial, 3 of 5 volunteers challenged by mosquitoes infected with NF135.C10 and 4 of 5 challenged with NF54 developed parasitemia as detected with microscopy. The 2 strains induced similar clinical signs and symptoms as well as cellular immunological responses. CLINICAL TRIALS REGISTRATION: NCT01002833.
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.